|
University of Helsinki, Helsinki 2004 A novel enzymic therapy, targeted recombinant beta-lactamase, in the prevention of antibiotic-induced adverse effects on gut microbiotaJaana HarmoinenAcademic Dissertation, February 2004.
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited. © University of Helsinki 2004 Viimeksi päivitetty 08.02.2004/JH |